0001969223-26-000773.txt : 20260708 0001969223-26-000773.hdr.sgml : 20260708 20260708161127 ACCESSION NUMBER: 0001969223-26-000773 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Bicara Therapeutics Inc. CENTRAL INDEX KEY: 0002023658 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-42271 FILM NUMBER: 261162508 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-468-4219 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Cohlhepp Ryan CENTRAL INDEX KEY: 0002034665 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: BICARA THERAPEUTICS INC. STREET 2: 116 HUNTINGTON AVENUE, SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 144 1 primary_doc.xml 144 0002034665 XXXXXXXX LIVE 0002023658 Bicara Therapeutics Inc. 001-42271 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219 Cohlhepp Ryan Officer Director Common UBS Financial Services, Inc

Eleven Madison Avenue 4th Floor New York NY 10010

28750 869687.50 65703866 07/08/2026 NASDAQ Common 05/12/2024 Exercise of Stock Option Issuer N 10000 05/12/2024 Cash Common 07/08/2026 Exercise of Stock Option Issuer N 18750 07/08/2026 Cash N Ryan Cohlhepp

116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116

Common 05/15/2026 12500 253648.75 Ryan Cohlhepp

116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116

Common 04/15/2026 12500 287591.25 07/08/2026 03/31/2026 /s/ UBS Financial Services Inc., as attorney-in-fact for Ryan Cohlhepp